Please login to the form below

Not currently logged in
Email:
Password:

Just Health PR wins Caris Life Sciences brief

Bioscience company to launches its tumour profiling technology in Europe

Just Health PR has been appointed by US bioscience company Caris Life Sciences to help introduce their tumour profiling technology to European markets.

Caris' molecular intelligence (MI) service provides oncologists with clinically actionable, individualised treatment information for solid tumours.

Using a combination of technologies, including next-generation sequencing (NGS), Caris sifts a database of peer-review and published cancer research papers, in order to correlate specific biomarkers to positive drug responses.

By comparing the genetic and molecular makeup unique to each patient's tumour with data from existing clinical studies, GPs can determine the course of treatment likely to be most effective for the individual patient.

Leading the Just Health PR push will be the agency's head of political relations, Jon Spiers, who said: "This is an incredibly fast-moving and innovative area of medicine which is of great interest to politicians and policymakers.

"We are thrilled to be working on a technology, which has the potential to revolutionise the way we treat cancer."

Because MI is neither a treatment nor a diagnostic, there is no clear measure for assessing its utility within the NHS. However, the Just team has begun talks with the Department of Health, the Technology Strategy Board, the NHS Technology Adoption Centre and the Downing Street Policy Unit to determine how the health service might adopt the technology.

12th February 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics